Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Language
Publication year range
1.
Int. j. morphol ; 37(1): 87-92, 2019. tab, graf
Article in English | LILACS | ID: biblio-990010

ABSTRACT

SUMMARY: This study aimed to investigate the toxic effects of cigarette smoke exposure on lung and the protective role of Omega 3 and Vitamin D against these toxic effects biochemically and histologically. 28 pregnant Wistar Albino rats were divided into four groups. The first group was control group; the second group was exposed to smoke of 10 cigarette by puff device 2 hours/day after pregnancy; the third group was exposed to cigarette smoke together with Omega 3 (0.5 mg/kg/day) and the fourth group was exposed to cigarette smoke together with vitamin D (42 microgram/kg/day). Finally, lung tissue sections of the newborn rats were stained with Hemotoxilen eosine and Masson tricromite. Malondialdehyde (MDA) and Fluorescent Oxidation Products (FOU) levels were measured. Fetal weights and the number of fetuses were significantly lower in the group received only cigarette smoke (both p<0.001). Histopathologically, pulmonary volume, number of developed alveols and parenchyma elasticity decreased significantly, meanwhile interstitial tissue increased, elastin and collagen did not develop adequately. Histopathologic changes significantly decreased in the group given Omega 3 and Vitamin D. Statistically, MDA and FOU levels were found to be higher in the group exposed to cigarette smoke compared to the control group, and MDA and FOU levels were lower in the group given Omega 3 along with cigarette smoke (p<0.001). Cigarette smoke caused histologically significant damage to fetal lung tissue, oxidative stress and increased MDA and FOU levels. This damage was significantly reduced with Omega 3 and Vitamine D supplementation. Omega 3 is an important antioxidant; vitamin D has no significant antioxidant effect.


RESUMEN: Este estudio tuvo como objetivo investigar los efectos tóxicos de la exposición al humo de cigarrillo en el pulmón, y el papel protector de Omega 3 y la Vitamina D contra esos efectos. 28 ratas Wistar albino preñadas fueron separadas en cuatro grupos. El primer grupo grupo control; el segundo grupo estuvo expuesto al humo de 10 cigarrillos por dispositivo de inhalación 2 horas / día después de la preñez; el tercer grupo se expuso al humo del cigarrillo junto con Omega 3 (0,5 mg / kg / día) y el cuarto grupo se expuso al humo del cigarrillo junto con vitamina D (42 microgramos / kg / día). Secciones de tejido pulmonar de las ratas recién nacidas se tiñeron con Hematoxilina Eosina y tricrómico de Masson. Se midieron los niveles de malondialdehído (MDA) y productos de oxidación fluorescente (POF). Los pesos fetales y el número de fetos fueron significativamente más bajos en el grupo que recibió solamente humo de cigarrillo (ambos p <0,001). Histopatológicamente, el volumen pulmonar, el número de alveolos desarrollados y la elasticidad del parénquima disminuyeron significativamente; mientras que el tejido intersticial aumentó y la elastina y el colágeno no se desarrollaron adecuadamente. Los cambios histopatológicos disminuyeron significativamente en el grupo que recibió Omega 3 y Vitamina D. Estadísticamente, se encontró que los niveles de MDA y POF eran más altos en el grupo expuesto al humo de cigarrillo en comparación con el grupo control, además los niveles de MDA y POF fueron más bajos en el grupo que recibió Omega 3 junto con el humo del cigarrillo (p <0,001). El humo del cigarrillo causó daños histológicamente significativos en el tejido pulmonar fetal, el estrés oxidativo y el aumento de los niveles de MDA y FOU. Este daño se redujo significativamente con los suplementos de Omega 3 y Vitamina D. El omega 3 es un importante antioxidante; la vitamina D no tiene ningún efecto antioxidante significativo.


Subject(s)
Animals , Female , Pregnancy , Rats , Vitamin D/administration & dosage , Fatty Acids, Omega-3/administration & dosage , Maternal Exposure/adverse effects , Lung Injury/prevention & control , Nicotine/toxicity , Smoke/adverse effects , Analysis of Variance , Rats, Wistar , Oxidative Stress , Lung Injury/chemically induced , Lung Injury/pathology , Fetus/drug effects , Fluorescence , Animals, Newborn , Malondialdehyde/analysis
2.
Turk J Med Sci ; 48(5): 1073-1079, 2018 Oct 31.
Article in English | MEDLINE | ID: mdl-30384578

ABSTRACT

Objectives: We observed the efficacy of melatonin in preventing ovarian tissue damage in rats exposed to magnetic fields. Materials and methods: Forty rats were divided into four treatment groups: Group 1, control group (n = 10); Group 2, melatonin administration only (n = 10); Group 3, magnetic field exposure only (n = 10); Group 4, magnetic field exposure with melatonin administration (n = 10). The magnetic field was applied at a dose of 20 µT for 30 min/day for 10 days. Melatonin was orally administered at a dose of 10 mg/kg. We evaluated follicle count, degree of fibrosis, amount of adhesion, amount of apoptosis, ovarian dimensions, and follicular degeneration by dissecting the ovaries of the rats on day 11, and differences among the groups were evaluated. Results: Group 3 had an increased amount of follicle degeneration, more fibrosis, and more adhesion than Group 4, but these findings were not statistically significant. The apoptosis scores in Groups 1 and 2 were significantly lower than in the other groups. Ovarian dimensions were significantly decreased in Group 3. Follicular degeneration was significantly increased in Group 3. Conclusion: Exogenously administered melatonin, if used at much higher doses orally, may be a noncytotoxic, antiapoptotic agent and may also have a protective effect on ovarian tissue damage that radiation can cause at the level of fine structure.


Subject(s)
Magnetic Fields/adverse effects , Melatonin/pharmacology , Ovary/drug effects , Ovary/radiation effects , Protective Agents/pharmacology , Animals , Female , Ovary/injuries , Ovary/pathology , Rats , Rats, Wistar
3.
Kulak Burun Bogaz Ihtis Derg ; 26(1): 7-11, 2016.
Article in English | MEDLINE | ID: mdl-26794329

ABSTRACT

OBJECTIVES: This study aims to investigate the possible impact of hormonal changes on nasal resonance during pregnancy. PATIENTS AND METHODS: Between January 2013 and June 2013, a total of 101 pregnant women (mean age 27.1±5.8 years; range 18 to 41 years) visiting obstetric clinics for routine antenatal checkups were included in the study. The control group was consisted of 99 patients (mean age 29.2±6.6 years; range 18 to 42 years) without any nasal complaints. Nasal symptoms were assessed using the Nasal Obstruction Symptom Evaluation (NOSE) Scale. Nasalance scores were calculated by nasometry. The results were compared between study and control groups. RESULTS: The mean nasalance score in pregnant women (40.4±7.8) were statistically significantly lower than the control group (44.7±6.4) (p<0.001). The nasalance score was 43.2±7.0 for the first trimester, 41.1±6.6 for the second trimester, and 39.2±8.8 for the third trimester. There was no statistically significant difference in nasalance scores within three trimesters. The mean nasalance scores of the second and third trimesters were statistically significantly lower than the control group (p<0.001). The NOSE scores were found to be statistically significantly higher in the third trimester (2.9±2.6) than the second trimester (1.1±1.9) (p<0.001). CONCLUSION: These findings indicate that nasalance scores fall in pregnancy, leading to the development of hyponasal voice.


Subject(s)
Pregnancy/physiology , Voice Quality , Adolescent , Adult , Case-Control Studies , Female , Humans , Speech Acoustics , Young Adult
4.
J Obstet Gynaecol Res ; 40(4): 1157-60, 2014 Apr.
Article in English | MEDLINE | ID: mdl-24612336

ABSTRACT

Hydatid disease is an endemic infection which can affect any organ, mainly the liver and lungs. Peritoneal echinococcosis is usually known to occur secondary to hepatic hydatid cyst rupture into the peritoneal cavity. An isolated cyst in the pelvic cavity is considered as primary only when there are no other hydatid cysts. Herein, we report an isolated pelvic-cervical hydatid cyst which presented without any involvement of the other abdominal organs or lungs. Our patient, a 27-year-old woman with the primary complaints of dyspareunia and chronic pelvic pain, had thin-walled large cystic mass originating from the cervix, diagnosed by ultrasonography. She underwent surgery with the most likely initial diagnosis of exophytic fibroid with cystic degeneration. Gynecologists should be aware of the possibility of isolated primary hydatid cyst of the pelvic cavity and should consider this condition in the differential diagnosis of cystic pelvic masses, especially in areas where the disease is endemic.


Subject(s)
Cervix Uteri/diagnostic imaging , Echinococcosis/diagnostic imaging , Peritoneal Diseases/diagnostic imaging , Uterine Cervical Diseases/diagnostic imaging , Adult , Albendazole/therapeutic use , Anthelmintics/therapeutic use , Cervix Uteri/parasitology , Cervix Uteri/surgery , Combined Modality Therapy , Cysts/diagnostic imaging , Diagnosis, Differential , Diagnostic Errors , Douglas' Pouch , Dyspareunia/etiology , Echinococcosis/parasitology , Echinococcosis/physiopathology , Echinococcosis/therapy , Female , Humans , Leiomyoma/diagnostic imaging , Pelvic Pain/etiology , Peritoneal Diseases/parasitology , Peritoneal Diseases/physiopathology , Peritoneal Diseases/therapy , Treatment Outcome , Turkey , Ultrasonography , Uterine Cervical Diseases/parasitology , Uterine Cervical Diseases/physiopathology , Uterine Cervical Diseases/therapy , Uterine Neoplasms/diagnostic imaging
SELECTION OF CITATIONS
SEARCH DETAIL
...